Patents show all

17Issued13Applications

Clinical Trials show all

3Phase 12Phase 21Phase 1/Phase 21Phase 3

SEC Filings show all

D4S-11

SEC Form D Funding Events

DateOfferedSoldType
2012-01-13$645,004$585,004Debt, Option to Acquire, Security to be Acquired
2011-06-23$1,080,377$1,080,377Debt, Option to Acquire, Security to be Acquired
2009-11-24$10,000,000$7,287,902Debt, Option to Acquire
2008-04-25UnknownUnknownOther (Paper Filing)

Key Executives

  • W. Thomas Amick
    Executive Officer, Director
  • Edward L. Field
    Executive Officer
  • David Carberry
    Executive Officer
  • Andrew E. Balber
    Executive Officer
  • Jim Hinson
    Executive Officer
  • Joel R. Kimbrough
    Director
  • Martin J. Murphy
    Director
  • B. Jefferson Clark
    Director
  • Garheng Kong
    Director
  • William E. Evans
    Director
  • Lyle A. Hohnke
    Director
  • Richard S Kent
    Director
  • Joel Kimbrough
    Director
  • Martin Murphy
    Director
  • B Jefferson Clark
    Director
  • William Evans
    Director
  • Lyle A Hohkne
    Executive Officer, Director
  • Dennis Dougherty
    Director
  • William W Brooke
    Director
  • James Hinson
    Executive Officer
  • Edward Field
    Executive Officer
  • Richard Kent
    Director
  • William Brooke
    Director